Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0171 Transporter Info
Gene Name	SLC25A13
Transporter Name	Calcium-binding mitochondrial carrier protein Aralar2
Gene ID	10165
UniProt ID	Q9UJS0

Post-Translational Modification of This DT
Overview ofSLC25A13 Modification Sites with Functional and Structural Information
Sequence	M A A A K V A L T K R A D P A E L R T I F L K Y A S I E K N G E F F M S P N D F V T R Y L N I F G E S Q P N P K T V E L L S G V V D Q T K D G L I S F Q E F V A F E S V L C A P D A L F M V A F Q L F D K A G K G E V T F E D V K Q V F G Q T T I H Q H I P F N W D S E F V Q L H F G K E R K R H L T Y A E F T Q F L L E I Q L E H A K Q A F V Q R D N A R T G R V T A I D F R D I M V T I R P H V L T P F V E E C L V A A A G G T T S H Q V S F S Y F N G F N S L L N N M E L I R K I Y S T L A G T R K D V E V T K E E F V L A A Q K F G Q V T P M E V D I L F Q L A D L Y E P R G R M T L A D I E R I A P L E E G T L P F N L A E A Q R Q K A S G D S A R P V L L Q V A E S A Y R F G L G S V A G A V G A T A V Y P I D L V K T R M Q N Q R S T G S F V G E L M Y K N S F D C F K K V L R Y E G F F G L Y R G L L P Q L L G V A P E K A I K L T V N D F V R D K F M H K D G S V P L A A E I L A G G C A G G S Q V I F T N P L E I V K I R L Q V A G E I T T G P R V S A L S V V R D L G F F G I Y K G A K A C F L R D I P F S A I Y F P C Y A H V K A S F A N E D G Q V S P G S L L L A G A I A G M P A A S L V T P A D V I K T R L Q V A A R A G Q T T Y S G V I D C F R K I L R E E G P K A L W K G A G A R V F R S S P Q F G V T L L T Y E L L Q R W F Y I D F G G V K P M G S E P V P K S R I N L P A P N P D H V G G Y K L A V A T F A G I E N K F G L Y L P L F K P S V S T S K A I G G G P
PTM type	X-Acetylation X-Malonylation X-Methylation X-O-glycosylation X-Oxidation X-Phosphorylation X-S-nitrosylation X-Succinylation X-Sulfoxidation X-Ubiquitination X: Amino Acid

Acetylation
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[1], [2]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	2
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A13 Alanine 2 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[3]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	485
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A13 Glycine 485 has the potential to affect its expression or activity.
Lysine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[4], [5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A13 Lysine 23 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	251
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A13 Lysine 251 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence SLC25A13			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	379
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A13 Lysine 379 has the potential to affect its expression or activity.
PTM Phenomenon4	Have the potential to influence SLC25A13			[7]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	405
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A13 Lysine 405 has the potential to affect its expression or activity.
PTM Phenomenon5	Have the potential to influence SLC25A13			[4], [8]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	484
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A13 Lysine 484 has the potential to affect its expression or activity.
PTM Phenomenon6	Have the potential to influence SLC25A13			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	662
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A13 Lysine 662 has the potential to affect its expression or activity.
Malonylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[9]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	580
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at SLC25A13 Lysine 580 has the potential to affect its expression or activity.
Methylation
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	379
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC25A13 Lysine 379 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[10]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	453
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC25A13 Lysine 453 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence SLC25A13			[11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	484
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC25A13 Lysine 484 has the potential to affect its expression or activity.
O-glycosylation
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[12], [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	361
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC25A13 Serine 361 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[12], [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	619
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC25A13 Serine 619 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence SLC25A13			[12], [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	625
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC25A13 Serine 625 has the potential to affect its expression or activity.
Oxidation
Cystine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[14]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	202
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC25A13 Cystine 202 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[14]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	377
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC25A13 Cystine 377 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence SLC25A13			[14]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	437
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC25A13 Cystine 437 has the potential to affect its expression or activity.
PTM Phenomenon4	Have the potential to influence SLC25A13			[14]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	503
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC25A13 Cystine 503 has the potential to affect its expression or activity.
PTM Phenomenon5	Have the potential to influence SLC25A13			[15]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	565
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC25A13 Cystine 565 has the potential to affect its expression or activity.
Phosphorylation
Leucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[16]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	658
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Leucine 658 has the potential to affect its expression or activity.
Serine	17 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	26
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 26 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	36
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 36 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence SLC25A13			[18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	51
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 51 has the potential to affect its expression or activity.
PTM Phenomenon4	Have the potential to influence SLC25A13			[18], [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	238
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 238 has the potential to affect its expression or activity.
PTM Phenomenon5	Have the potential to influence SLC25A13			[18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	314
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 314 has the potential to affect its expression or activity.
PTM Phenomenon6	Have the potential to influence SLC25A13			[20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	361
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 361 has the potential to affect its expression or activity.
PTM Phenomenon7	Have the potential to influence SLC25A13			[20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	364
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 364 has the potential to affect its expression or activity.
PTM Phenomenon8	Have the potential to influence SLC25A13			[21], [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	469
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 469 has the potential to affect its expression or activity.
PTM Phenomenon9	Have the potential to influence SLC25A13			[21], [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	472
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 472 has the potential to affect its expression or activity.
PTM Phenomenon10	Have the potential to influence SLC25A13			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	510
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 510 has the potential to affect its expression or activity.
PTM Phenomenon11	Have the potential to influence SLC25A13			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	519
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 519 has the potential to affect its expression or activity.
PTM Phenomenon12	Have the potential to influence SLC25A13			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	522
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 522 has the potential to affect its expression or activity.
PTM Phenomenon13	Have the potential to influence SLC25A13			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	536
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 536 has the potential to affect its expression or activity.
PTM Phenomenon14	Have the potential to influence SLC25A13			[24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	619
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 619 has the potential to affect its expression or activity.
PTM Phenomenon15	Have the potential to influence SLC25A13			[20], [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	664
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 664 has the potential to affect its expression or activity.
PTM Phenomenon16	Have the potential to influence SLC25A13			[20], [26]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	666
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 666 has the potential to affect its expression or activity.
PTM Phenomenon17	Have the potential to influence SLC25A13			[20], [27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	668
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Serine 668 has the potential to affect its expression or activity.
Threonine	11 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[28], [29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 9 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	68
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 68 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence SLC25A13			[19], [30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	239
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 239 has the potential to affect its expression or activity.
PTM Phenomenon4	Have the potential to influence SLC25A13			[19], [30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	243
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 243 has the potential to affect its expression or activity.
PTM Phenomenon5	Have the potential to influence SLC25A13			[31]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	250
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 250 has the potential to affect its expression or activity.
PTM Phenomenon6	Have the potential to influence SLC25A13			[20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	362
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 362 has the potential to affect its expression or activity.
PTM Phenomenon7	Have the potential to influence SLC25A13			[22], [32]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	463
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 463 has the potential to affect its expression or activity.
PTM Phenomenon8	Have the potential to influence SLC25A13			[22]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	464
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 464 has the potential to affect its expression or activity.
PTM Phenomenon9	Have the potential to influence SLC25A13			[23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	539
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 539 has the potential to affect its expression or activity.
PTM Phenomenon10	Have the potential to influence SLC25A13			[33]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	599
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 599 has the potential to affect its expression or activity.
PTM Phenomenon11	Have the potential to influence SLC25A13			[20], [25]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	667
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Threonine 667 has the potential to affect its expression or activity.
Tyrosine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[30]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	237
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Tyrosine 237 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[33]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	600
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Tyrosine 600 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence SLC25A13			[16]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	657
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Tyrosine 657 has the potential to affect its expression or activity.
Valine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[16]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	665
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A13 Valine 665 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[34]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	377
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC25A13 Cystine 377 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[35]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	503
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC25A13 Cystine 503 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence SLC25A13			[34]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	565
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC25A13 Cystine 565 has the potential to affect its expression or activity.
Succinylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	484
Experimental Method	Co-Immunoprecipitation
Detailed Description	Succinylation at SLC25A13 Lysine 484 has the potential to affect its expression or activity.
Sulfoxidation
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[36]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	267
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at SLC25A13 Methionine 267 has the potential to affect its expression or activity.
Ubiquitination
Alanine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	488
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Alanine 488 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	498
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Alanine 498 has the potential to affect its expression or activity.
Asparticacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	350
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Asparticacid 350 has the potential to affect its expression or activity.
Glutamicacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	200
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Glutamicacid 200 has the potential to affect its expression or activity.
Glycine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	481
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Glycine 481 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[3], [37]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	485
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Glycine 485 has the potential to affect its expression or activity.
Histidine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Histidine	Modified Location	124
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Histidine 124 has the potential to affect its expression or activity.
Leucine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Leucine 203 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	409
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Leucine 409 has the potential to affect its expression or activity.
Lysine	11 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[38]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 23 has the potential to affect its expression or activity.
PTM Phenomenon2	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	69
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 69 has the potential to affect its expression or activity.
PTM Phenomenon3	Have the potential to influence SLC25A13			[38]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	104
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 104 has the potential to affect its expression or activity.
PTM Phenomenon4	Have the potential to influence SLC25A13			[38]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	251
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 251 has the potential to affect its expression or activity.
PTM Phenomenon5	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	353
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 353 has the potential to affect its expression or activity.
PTM Phenomenon6	Have the potential to influence SLC25A13			[39]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	379
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 379 has the potential to affect its expression or activity.
PTM Phenomenon7	Have the potential to influence SLC25A13			[39]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	380
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 380 has the potential to affect its expression or activity.
PTM Phenomenon8	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	405
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 405 has the potential to affect its expression or activity.
PTM Phenomenon9	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	408
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 408 has the potential to affect its expression or activity.
PTM Phenomenon10	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	484
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 484 has the potential to affect its expression or activity.
PTM Phenomenon11	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	487
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Lysine 487 has the potential to affect its expression or activity.
Phenylalanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	419
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Phenylalanine 419 has the potential to affect its expression or activity.
Proline	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	495
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Proline 495 has the potential to affect its expression or activity.
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	364
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Serine 364 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon1	Have the potential to influence SLC25A13			[37]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	354
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A13 Threonine 354 has the potential to affect its expression or activity.

References
1	N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
2	N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24.
3	Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40.
4	Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell. 2015 Sep 3;59(5):867-81.
5	Suberoylanilide hydroxamic acid treatment reveals crosstalks among proteome, ubiquitylome and acetylome in non-small cell lung cancer A549 cell line. Sci Rep. 2015 Mar 31;5:9520.
6	Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab. 1990 Aug;71(2):492-6.
7	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: CMC2_HUMAN)
8	Regulation of cellular metabolism by protein lysine acetylation. Science. 2010 Feb 19;327(5968):1000-4.
9	Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
10	Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics. 2014 Jan;13(1):372-87.
11	Clinical applications of the enzyme labeled antibody method. Immunoperoxidase methods in diagnostic histopathology. J Histochem Cytochem. 1979 Aug;27(8):1140-7.
12	A triarylphosphine-trimethylpiperidine reagent for the one-step derivatization and enrichment of protein post-translational modifications and identification by mass spectrometry. Chem Commun (Camb). 2018 Dec 6;54(98):13790-13793.
13	Combinatorial regulation of hepatic cytoplasmic signaling and nuclear transcriptional events by the OGT/REV-ERBalpha complex. Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11033-E11042.
14	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
15	Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
16	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
17	The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol Cell Proteomics. 2011 Jan;10(1):M110.004457.
18	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
19	Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. Cell Metab. 2015 Nov 3;22(5):922-35.
20	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
21	Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation. J Proteome Res. 2010 Dec 3;9(12):6786-94.
22	Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
23	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
24	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
25	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
26	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
27	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
28	Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
29	Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One. 2014 Mar 26;9(3):e90948.
30	System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal. 2011 Mar 15;4(164):rs3.
31	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
32	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
33	Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res. 2012 May 4;11(5):2828-37.
34	Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection. Circ Res. 2015 Oct 23;117(10):846-57.
35	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
36	Redox-based reagents for chemoselective methionine bioconjugation. Science. 2017 Feb 10;355(6325):597-602.
37	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
38	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
39	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence